Linkage Bio Raises $2M; Inks Distribution Partnerships | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostic firm Linkage Biosciences today announced it raised $2 million in growth capital.

The company did not specify how the funds will be used, but CEO Zachary Antovich noted growing demand for the firm's LinkSeq products and said in a statement that the funds will "help accelerate our efforts around the world."

Fisher Capital led the round. All existing investors, including Greenhouse Capital Partners and Big Sky Partners, also participated, Linkage Bio said

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The hashtag #stupidcommonnames is gaining fans among scientists who find the common names of some animals and plants dumb.

Fed up with budget slashes, job cuts, and muzzling mandates, researchers in Canada are making science a campaign issue in the upcoming elections.

A former NIH program officer says the Internet has blasted open the door for scientific publications more interested in dollars than quality research.

This Week in Science: New research into the emergence of infectious diseases, and scientists report on proteins involved in melanoma.